GSK Partners with Muna Therapeutics to Advance Alzheimer’s Treatment Research

Partnership:
GSK has partnered with Muna Therapeutics, a biotech startup, to advance Alzheimer's drug research12.

Focus:
The collaboration focuses on using Muna's innovative technology to uncover disease-causing targets for Alzheimer's treatment2.

Financial Terms:
Muna will receive an upfront payment and potential milestone payments for identifying new drug targets, while GSK will handle development and commercialization2.

Renewed Commitment:
This partnership signifies GSK's renewed commitment to neuroscience, leveraging Muna's expertise in genetic code analysis to discover new treatment targets for neurodegenerative diseases2.

Muna Therapeutics:
Muna is a transatlantic biotech startup founded less than four years ago, focusing on genetic code analysis to discover new treatment targets for neurodegenerative diseases12.

Sources:

1. https://endpts.com/gsks-third-new-pact-of-the-week-focuses-on-alzheimers-with-startup-muna-therapeutics/

2. https://healtheconomics.com/gsk-and-muna-therapeutics-partner-to-target-alzheimers-treatment/